Quantitative assessment of aberrant P16INK4a methylation in ovarian cancer: a meta-analysis based on literature and TCGA datasets
Jie Ruan,1,* Peipei Xu,2,3,* Wei Fan,4 Qiaoling Deng,3 Mingxia Yu3 1Key Laboratory for Medical Molecular Diagnostics of Guangdong, Guangdong Medical University, Dongguan, Guangdong, 523808, China; 2Department of Clinical Laboratory, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, H...
Main Authors: | Ruan J, Xu P, Fan W, Deng Q, Yu M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-08-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/quantitative-assessment-of-aberrant-p16ink4a-methylation-in-ovarian-ca-peer-reviewed-article-CMAR |
Similar Items
-
Aberrant p16INK4A methylation: Relation to viral related chronic liver disease and hepatocellular carcinoma
by: Fatma A El-Mougy, et al.
Published: (2014-01-01) -
Methylation of p16 ink4a promoter is independent of human papillomavirus DNA physical state: a comparison between cervical pre-neoplastic and neoplastic samples
by: Fernanda Nahoum Carestiato, et al.
Published: (2018-12-01) -
DNA methylation subtypes for ovarian cancer prognosis
by: Lili Yin, et al.
Published: (2021-03-01) -
Investigating CpG islands methylation in P16/Ink4 gene promoter regions and the effect of Interleukin-17 gene polymorphism on this methylation in patients with breast cancer
by: Sirous Naeimi
Published: (2018-04-01) -
Identification by TCGA database search of five genes that are aberrantly expressed and involved in hepatocellular carcinoma potentially via DNA methylation changes
by: Junya Matsushita, et al.
Published: (2020-07-01)